1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow regdanvimab: new trials by email Literature Review of regdanvimab trials Research Report on regdanvimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Tixagevimab/Cilgavimab and Regdanvimab Efficacy for Treatment of COVID-19 tixagevimab/cilgavimab 150+150 mg, tixagevimab/cilgavimab 300+300 mg, regdanvimab - Coronavirus Infections | Phase 4 | Unknown | City Clinical Hospital No.52 of Moscow Healthcare Department | 82 | 2022-08-18 | 2023-08-08 |
City Clinical Hospital No.52 of Moscow Healthcare Department (1)
Russia (1)